The market for tissue engineering and cell therapy products is set to grow to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall [...]
Historically, closure of surgical incisions has been achieved through an ever-evolving portfolio of suture, staple and tape products. In the early 1990s, physicians involved in sports medicine were the first non-military practitioners to adopt cyanoacrylate glues to achieve immediate closure of small cuts and lacerations, and an awareness of this opportunity developed in large multinational [...]
The subject of "tissue engineering and cell therapy" is, by some accounts, an artificial amalgam of the two separate subjects, particularly since cell therapy per se, as a result of its inextricable link to embryonic stem cells and abortion, seems to demand (at least by some) a wholly separate consideration. From a scientific basis, of [...]
The market for surgical closure and securement has entered a phase in which the major driving forces are the introduction of new procedures and techniques by the surgical profession, the development by the medical device industry of new wound closure devices and biomaterials, and the growing willingness of surgical specialists to use these devices in [...]
Researchers at the University of Akron have revealed the evolutionary strength of spider web glue. Published in the May 17, 2010, issue of Nature Communications, the research revealed that the effectiveness and strength of the spider web glue ensues from the highly entangled, cross-linked polymers in each droplet of the glue, which enables the adhesive [...]
The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice. Below is a sample of surgical sealants, glues and wound closure applications by clinical area: Source: [...]
The field of tissue glue and sealants has been prolific for its formation of new companies pursuing the development and marketing of these products for medical and surgical applications. (The MedMarket Diligence report #S175 profiles 136 companies active in this market.) As the market for these products has moved past its infancy and more companies [...]
Cellular therapeutics with neurology applications currently encompass the entire range of development from preclinicals to approved, commercially available products in use. See the specific selected neurology cell therapy products on the market or in development by companies in the market: Personalized stem cell therapies for tissue regeneration Cell treatment for amyotropic lateral sclerosis Biopharmaceutical for [...]
In today's issue (4/12/2010) of NYT, more coverage is given to the variety of naturally occurring "glues" that are being studied for their potential as medical/surgical glues in humans. See also our recent coverage of such bio-glues under study. The trait of adhesiveness has proven itself to be the result of environmental demands driving their evolutionary [...]
The search for synthetic-based biocompatible materials has posed particular problems for researchers in that no synthetic material is completely accepted and integrated by the body. Therefore, the goal has been to create a replacement tissue that closely mimics natural tissue and will activate normal body healing and tissue reconstruction, and eventually be resorbed harmlessly into [...]
Contact:
